Skip to content
Facebook page opens in new windowInstagram page opens in new windowYouTube page opens in new window
Search:
DONATE
ALD Connect
ALD ConnectALD Connect
  • About Us
    • Mission
    • Board of Directors
    • The Myelin Project
    • Our Partners
  • What is ALD?
    • ALD Centers and Experts
    • Newborn Screening/Asymptomatic
    • Adrenal Insufficiency
    • Cerebral ALD
    • Adrenomyeloneuropathy (AMN)
    • Symptomatic Women
  • Clinical Trials & Research
    • Clinical Trials
    • Emerging Investigators
    • The Grey Zone
    • Laboratories
    • Publications
  • Resources
    • Annual Meetings and Patient Learning Academies
    • EL-PFDD
    • Financial Assistance
    • Frequently Asked Questions
    • Mental Health
    • Peer Mentor Program
    • Webinars
  • Get Involved
    • Advocate
    • ALD Landscape Project
    • Community Calendar
    • Community Calls
    • Community Directory
  • News
  • Contact Us
  • About Us
    • Mission
    • Board of Directors
    • The Myelin Project
    • Our Partners
  • What is ALD?
    • ALD Centers and Experts
    • Newborn Screening/Asymptomatic
    • Adrenal Insufficiency
    • Cerebral ALD
    • Adrenomyeloneuropathy (AMN)
    • Symptomatic Women
  • Clinical Trials & Research
    • Clinical Trials
    • Emerging Investigators
    • The Grey Zone
    • Laboratories
    • Publications
  • Resources
    • Annual Meetings and Patient Learning Academies
    • EL-PFDD
    • Financial Assistance
    • Frequently Asked Questions
    • Mental Health
    • Peer Mentor Program
    • Webinars
  • Get Involved
    • Advocate
    • ALD Landscape Project
    • Community Calendar
    • Community Calls
    • Community Directory
  • News
  • Contact Us

Poxel Announces its Participation at Upcoming Scientific Conferences Related to Adrenoleukodystrophy (ALD)

UncategorizedBy KellyOctober 25, 2021

Poxel Announces its Participation at Upcoming Scientific Conferences Related to Adrenoleukodystrophy (ALD) LYON, France–(BUSINESS WIRE)– POXEL SA (Euronext – POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic…

© ALD Connect | Website Design & Website Development by Surf Your Name.
Go to Top